SPEAKER INDEX CONTENTS INSERTS APPEAL OF DETERMINATIONS OF THE COMMISSIONER 18 APPLICATION FEE 18 BERDON 98 166 172 BERMAN 21 30 66 157 158 161 162 163 164 170 171 172 173 180 181 182 183 185 186 238 239 240 241 242 245 246 247 248 BERRY 60 BINDER 190 192 236 237 242 244 245 246 247 248 BLAINE MERRITT 4 BLUNT 13 BONO 13 BRYANT 13 29 36 42 66 BURGOON 219 238 243 244 CANNON 175 176 177 178 179 COBLE 10 11 12 20 24 27 28 29 30 35 36 42 48 60 66 67 69 84 98 112 124 130 141 144 153 154 155 156 157 159 164 166 167 169 170 171 172 173 174 175 179 180 183 186 187 190 191 192 203 219 235 236 237 238 242 245 249 COMPENSATION 19 CONYERS 13 27 COURT JURISDICTION 18 CUNNINGHAM 10 11 DEAR CHAIRMAN COBLE 110 168 265 DEAR JOHN 82 DEAR MR. ANSELL 80 DEAR MR. BINDER 249 DEAR MR. CHAIRMAN 261 263 DEAR ORRIN 159 DEAR PETER 83 DEAR REPRESENTATIVE DELAHUNT 255 DEAR SENATOR HATCH 151 DEBBIE K. LAMAN 4 DEFINITIONS 14 DELAHUNT 13 24 DOWNEY 67 84 165 182 DUNCAN 13 EFFECT OF FILING OF ABBREVIATED APPLICATIONS 19 EFFECTIVE DATE 20 EMERSON 13 ESHOO 13 EUNICE GOLDRING 4 FILING AND DETERMINATION 16 FORD 13 FRANKS 13 FREDERICK S. ANSELL, ESQUIRE 80 FRELINGHUYSEN 13 GALLEGLY 173 174 187 242 243 244 245 GOODLATTE 174 175 GORDON 13 GORDON M. BINDER 249 HENRY J. HYDE 167 HILLEARY 13 HOWARD COBLE 110 260 262 265 HOYER 13 HUTT 70 156 157 158 162 163 164 174 175 180 181 182 184 185 IN GENERAL 14 19 INFRINGEMENT 16 INTERIM RESTORATION 17 JACKSON-LEE 13 JENKINS 13 JOHN P. MCLAUGHLIN, ESQUIRE 82 JULIAN EPSTEIN 3 KEALEY 130 167 169 170 LEHMAN 69 124 155 158 183 LIMITS ON LIABILITY 19 MCDERMOTT 13 42 MENENDEZ 13 MEYER 141 155 176 177 MITCH GLAZIER 4 ORR 144 179 ORRIN G. HATCH 159 ORRIN HATCH 151 PASTOR 13 PATENT TERM RESTORATION 13 PAYNE 13 PETER BARTON HUTT 83 PROCEDURE 16 RECORD 17 RECORDS 15 REPORT 20 RESTORATION TERM 15 ROBERT RABEN 4 ROTHMAN 13 SELDEN 203 235 237 238 239 240 241 248 SMITH 13 SPECIAL PATENT TERM REVIEW PROCEDURE 14 SPICEHANDLER 112 154 177 178 184 ST SESSION 13 STANDARDS 14 TAUSCHER 13 TECHNICAL AND CONFORMING AMENDMENT 18 TH CONGRESS 13 THOMAS E. MOONEY, SR 3 TIME FOR FILING 16 TORRICELLI 29 30 35 VINCE GARLOCK 4 WAMP 13 WAXMAN 48 49 WICKER 13 WILLIAM DELAHUNT 255 CONTENTS SPEAKERS INSERTS OPENING STATEMENT OF CHAIRMAN COBLE PAGE 10 STATEMENT OF HON. ROBERT G. TORRICELLI, A U.S. SENATOR FROM THE STATE OF NEW JERSEY PAGE 29 STATEMENT OF HON. ED BRYANT, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF TENNESSEE PAGE 36 STATEMENT OF HON. JIM MCDERMOTT, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF WASHINGTON PAGE 42 STATEMENT OF HON. HENRY A. WAXMAN, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF CALIFORNIA PAGE 48 STATEMENT OF HON. MARION BERRY, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF ARKANSAS PAGE 60 STATEMENT OF PETER BARTON HUTT, PARTNER, COVINGTON AND BURLING PAGE 70 STATEMENT OF BRUCE L. DOWNEY, CHAIRMAN, CEO, AND PRESIDENT, BARR LABORATORIES PAGE 84 STATEMENT OF ANDREW M. BERDON, VICE PRESIDENT AND GENERAL COUNSEL, PUREPAC PHARMACEUTICAL COMPANY, ON BEHALF OF THE COALITION FOR AFFORDABLE PHARMACEUTICALS PAGE 98 STATEMENT OF JONATHAN R. SPICEHANDLER, M.D., PRESIDENT, SCHERING-PLOUGH RESEARCH INSTITUTE PAGE 112 STATEMENT OF BRUCE LEHMAN, PRESIDENT AND CEO, INTERNATIONAL INTELLECTUAL PROPERTY INSTITUTE PAGE 124 STATEMENT OF MAURA KEALEY, DEPUTY DIRECTOR, PUBLIC CITIZEN'S CONGRESS WATCH PAGE 130 STATEMENT OF GERALD F. MEYER, SENIOR CONSULTANT, AAC CONSULTING GROUP, INC. PAGE 141 STATEMENT OF WILLIAM ORR, CHAIRMAN, NATIONAL ALTERNATIVE FUELS ASSOCIATION PAGE 144 STATEMENT OF GORDON BINDER, CEO, AMGEN PAGE 190 STATEMENT OF RICHARD SELDEN, M.D., CEO, TRANSKARYOTIC THERAPIES, INC. (TRT) PAGE 203 STATEMENT OF RICHARD P. BURGOON, JR., VICE PRESIDENT, GENERAL COUNSEL, AND ASSISTANT SECRETARY, ARENA PHARMACEUTICALS, INC. PAGE 219 INSERTS SPEAKERS CONTENTS